HomeCompareRKSLF vs MRK

RKSLF vs MRK: Dividend Comparison 2026

RKSLF yields 0.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.8K in total portfolio value
10 years
RKSLF
RKSLF
● Live price
0.22%
Share price
$9.06
Annual div
$0.02
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$22.72
Full RKSLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RKSLF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRKSLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RKSLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RKSLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RKSLF
Annual income on $10K today (after 15% tax)
$19.03/yr
After 10yr DRIP, annual income (after tax)
$19.31/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,309.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RKSLF + MRK for your $10,000?

RKSLF: 50%MRK: 50%
100% MRK50/50100% RKSLF
Portfolio after 10yr
$38.4K
Annual income
$4,910.43/yr
Blended yield
12.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RKSLF
No analyst data
Altman Z
4.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RKSLF buys
0
MRK buys
0
No recent congressional trades found for RKSLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRKSLFMRK
Forward yield0.22%2.76%
Annual dividend / share$0.02$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20.0K$56.8K
Annual income after 10y$22.72$9,798.13
Total dividends collected$226.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RKSLF vs MRK ($10,000, DRIP)

YearRKSLF PortfolioRKSLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,722$22.39$11,206$366.19$484.00MRK
2$11,495$22.43$12,650$502.35$1.2KMRK
3$12,323$22.48$14,407$694.19$2.1KMRK
4$13,208$22.52$16,585$967.82$3.4KMRK
5$14,155$22.56$19,342$1,363.89$5.2KMRK
6$15,168$22.59$22,913$1,947.19$7.7KMRK
7$16,253$22.63$27,662$2,823.89$11.4KMRK
8$17,413$22.66$34,159$4,173.35$16.7KMRK
9$18,654$22.69$43,337$6,308.80$24.7KMRK
10$19,983$22.72$56,776$9,798.13$36.8KMRK

RKSLF vs MRK: Complete Analysis 2026

RKSLFStock

Raksul Inc. provides printing services in Japan. The company offers printing for office/industry supplies, such as labels, clothing, stationary, mobile phone peripherals, bags, and cardboard and packaging materials; and flyers, business cards, booklets, envelopes, postcards, etc. It also provides local advertising services through inserted leaflets, posting, direct mails, TV commercials, and websites. In addition, the company operates advertising, TV commercial-related, logistics, and corporate IT platforms. Raksul Inc. was incorporated in 2009 and is headquartered in Tokyo, Japan.

Full RKSLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RKSLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RKSLF vs SCHDRKSLF vs JEPIRKSLF vs ORKSLF vs KORKSLF vs MAINRKSLF vs JNJRKSLF vs ABBVRKSLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.